Skip to main content
Clinical Ophthalmology (Auckland, N.Z.) logoLink to Clinical Ophthalmology (Auckland, N.Z.)
. 2018 May 17;12:913. doi: 10.2147/OPTH.S168970

Ocular comfort assessment of lifitegrast ophthalmic solution 5.0% in OPUS-3, a Phase III randomized controlled trial [Corrigendum]

PMCID: PMC5963829  PMID: 29845978

Nichols KK, Holland E, Toyos MM, et al. Ocular comfort assessment of lifitegrast ophthalmic solution 5.0% in OPUS-3, a Phase III randomized controlled trial. Clin Ophthalmol. 2018;12:263–270.

On page 266, both mentions of Figure 3, should be Figure 4.

Figure 4.

Figure 4

Drop comfort scores at 5, 10, and 15 minutes postinstillation among participants with drop comfort score >3 at 3-minute assessment (safety population; numbers above bars indicate participant numbers).

Note: Drop comfort score (scale, 0–10; 0 = very comfortable, 10 = very uncomfortable); drop discomfort corresponds to scores >3.

On page 267, Figure 4 is drawn incorrectly, the correct figure appears below:


Articles from Clinical Ophthalmology (Auckland, N.Z.) are provided here courtesy of Dove Press

RESOURCES